Pandemic Perspectives
This is the latest article in our series taking stock of possible lasting implications of the COVID-19 one year after the World Health Organization declared it a global pandemic.
COVID-19 has been the most comprehensive test case for the US Food and Drug Administration’s emergency use authorization pathway since Congress enacted the 2004 Project Bioshield Act giving the agency the ability to permit use of unapproved products against a threat to public health and safety.